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The Hedgehog signaling pathway is critical for a significant number of developmental patterning events. In this study, we focus on the
defects in pharyngeal arch and cardiovascular patterning present in Sonic hedgehog (Shh) null mouse embryos. Our data indicate that, in the
absence of Shh, there is general failure of the pharyngeal arch development leading to cardiac and craniofacial defects. The cardiac phenotype
results from arch artery and outflow tract patterning defects, as well as abnormal development of migratory neural crest cells (NCCs). The
constellation of cardiovascular defects resembles a severe form of the human birth defect syndrome tetralogy of Fallot with complete
pulmonary artery atresia. Previous studies have demonstrated a role for Shh in NCC survival and proliferation at later stages of development.
Our data suggest that SHH signaling does not act directly on NCCs as a survival factor, but rather acts to restrict the domains that NCCs can
populate during early stages (e8.5–10.5) of cardiovascular and craniofacial development.
D 2005 Elsevier Inc. All rights reserved.Keywords: Cardiac; Neural crest; Migration; Pulmonary atresia; Tetralogy of Fallot; Outflow tract; Septation; Anterior heart field; Bmp4; RepulsionIntroduction
Shh is one of three mammalian gene homologues of the
extracellular signaling molecule, Hedgehog, first described
as a segment polarity gene product in Drosophila (Nusslein-
Volhard and Wieschaus, 1980). Previous loss-of-function
studies in the mouse have demonstrated that Shh is required
for patterning of several organs such as the nervous system,
limbs, lungs, and foregut (Chiang et al., 1996; Litingtung et
al., 1998, 2002). Mouse embryos that are homozygous null
for Shh (Shh/) are also known to have pharyngeal arch0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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53706, USA.and cardiac defects, but the etiology of these defects has yet
to be described in detail (Izraeli et al., 1999; Kim et al.,
2001; Meyers and Martin, 1999; Tsukui et al., 1999).
NCCs are ecto-mesenchymal cells that migrate from the
junction of the surface ectoderm and neuroectoderm along
the dorsal neural tube to populate numerous structures
throughout the embryo. Cranial NCCs arise from the
forebrain and hindbrain regions to populate craniofacial
structures, as well as pharyngeal arches one through three,
giving rise to the maxilla, mandible, and other structures of
the neck and face (reviewed in Le Douarin and Dupin, 2003;
Santagati and Rijli, 2003). Cardiac NCCs populate the third,
fourth, and sixth pharyngeal arches, as well as the outflow
tract (OT) of the heart and contribute to the smooth muscle
of arch arteries in both chick (Kuratani and Kirby, 1992;
Nishibatake et al., 1987) and mouse (Jiang et al., 2000).
Ablation and genetic studies have shown that NCC
production, delamination, directed migration, and survival283 (2005) 357 – 372
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et al., 2002; Hutson and Kirby, 2003; Maschhoff and
Baldwin, 2000). Recent evidence suggests that SHH
function is required for NCC survival in chick (Ahlgren
and Bronner-Fraser, 1999; Ahlgren et al., 2002) and mouse
(Jeong et al., 2004). In this last study, a direct requirement
for Hedgehog signals in the development of murine
craniofacial NCCs was demonstrated by genetically remov-
ing the Smoothened (Smo) receptor from migratory NCCs.
However, this effect on NCCs appeared after mid-gestation
and was not as severe as that demonstrated by functional
blocking studies in chick embryos or by the phenotype of
Shh/ mouse embryos, suggesting an additional earlier cell
autonomous role for Shh in NCC development.
In this study, we sought to characterize the early (e9.5–
11.5) cardiovascular and pharyngeal arch development of
Shh/ mouse embryos to better understand how Shh
expression affects NCC development and these tissues. Our
data indicate that Shh is required for both NCC and
pharyngeal endoderm survival and support Shh as a
candidate gene defective in patients with tetralogy of Fallot,
as well as a possible modifying locus for the 22q11deletion
syndromes. Furthermore, mislocalization of NCC deriva-
tives in Shh/ embryos supports a model where SHH
signaling is required for NCC guidance cues.Materials and methods
Experimental animals
Mouse strains were maintained on an outbred ICR
background unless otherwise indicated. This background
was chosen because of the multiple transgenes used and the
late-term survival with consistent cardiovascular defects. In
addition, cardiac looping reversals were absent in Shh/
embryos on this outbred background, simplifying the
analysis of cardiac development at later stages and consistent
with previous studies (Izraeli et al., 1999; Tsukui et al.,
1999). Shh/ embryos were generated by intercrossing
Shh+/ (Shhtm1Chg) males and females (Chiang et al., 1996).
Noon on the day of vaginal plug was designated embryonic
(e) day 0.5. More accurate staging was then determined by
somite number. Genotyping was by phenotype (late stages)
or PCR (early stages) as described (Chiang et al., 1996). All
embryos were dissected in either DEPC (diethylpolycarbo-
nate)-treated phosphate-buffered saline (PBS) or PBS with
0.1%Triton X-100 (PBT). Fixation was at 4-C overnight in
4% paraformaldehyde (PFA) unless otherwise specified.
Cardiovascular system visualization in Shh/ embryos
Shh+/ males also transgenic for the Tie2-LacZ transgene
(Tg(TIE2-lacZ)182Sato/J), in which LacZ is controlled by a
Tie2 endothelial-cell-specific promoter element (Schlaeger
et al., 1997), were crossed to Shh+/ females to visualizeendothelial structures in Shh/ embryos. The chest wall/
pericardial sac was opened by blunt dissection to better
expose the heart and vessels. Embryos were then fixed and
washed. h-galactosidase (h-Gal) activity was detected by X-
Gal staining. Following staining, embryos were washed,
post fixed (4% PFA), and either cleared in 50% glycerol in
PBS for whole mount visualization or embedded in paraffin
for sectioning using standard procedures (Hogan, 1994).
Generation of Shh/;P0-Cre;R26R embryos
In order to lineage trace NCCs in Shh/ embryos, we
generated studs that were Shh+/ and transgenic for P0-Cre
(tg(P0-Cre)1Ky), which expresses the Cre transgene in
migratory NCC precursors (Abu-Issa et al., 2002; Yamauchi
et al., 1999). These transgenic studs were crossed with Shh+/
female mice that were also transgenic for the CRE reporter,
R26R (Gt(Rosa)26Sortm1Sor), which irreversibly expresses
LacZ in cells that have undergone recombination by the CRE
protein (Soriano, 1999). This method allowed us to effec-
tively compare lineage-marked NCCs in Shh/ and control
embryos. Wnt1-Cre (Tg(Wnt1-cre)11Rth) males (Danielian
et al., 1998) were crossed to R26R females to compare to P0-
Cre pattern. Embryos were fixed, stained for h-Gal activity,
and cleared as described above.
Ptch1LacZ
Ptch1LacZ, (Ptchtm1Mps) with LacZ inserted into the
Ptch1 locus, is heterozygous null for Ptch1 function
(Goodrich et al., 1997). Embryos expressing Ptch1LacZ
were generated on Shh+/ and Shh/ backgrounds by
generating Shh+/;Ptch1LacZ/+ males that were crossed to
Shh+/ females.
In situ hybridization
Whole-mount mRNA in situ hybridization was per-
formed as described previously (Neubuser et al., 1997)
using digoxygenin-labeled antisense riboprobes constructed
from linearized plasmids. Riboprobes were constructed for
Pax1, Ap2a, CrabP1, Bmp4, Sox9, and Twist. Embryos
were examined at stages indicated within text and figures.
All in situ hybridization results were confirmed in at least
three Shh/ mutant embryos and three control embryos
that were treated identically.
Whole-mount immunohistochemistry
Immunohistochemistry (IHC) was performed on whole
embryos that were fixed and washed in PBS with
0.1%Triton X-100 (PBT). Embryos were placed in blocking
solution (BS = 3% bovine serum albumin and 10% sheep or
horse serum in PBT) for 1 h then incubated in primary
antibody in BS at 4-C overnight. Control embryos were
incubated similarly but not exposed to primary antibody.
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diluted 1:5 in PBT, and incubated overnight with secondary
antibody in BS. Embryos were washed three times for 1
h each in block diluted 1:5 in PBT and mounted with
DABCO or benzyl alcohol:benzyl benzoate as described
(Zucker et al., 1999).
Cranial nerves/dorsal root ganglia (DRGs) were visual-
ized with 2H3 antibody (Developmental Studies Hybridoma
Bank and developed by T. Jessel and J. Dodd), as described
previously (Swiatek and Gridley, 1993) at a primary dilution
of 1:100. Cell proliferation was determined by presence of
phosphorylated histone H3 (PH3) using anti-phosphorylated
rabbit PH3 primary antibody (Upstate Biotechnology)
diluted 1:1000.
Cell death analysis
Cell death was demonstrated in whole embryos using
Lysotrackeri Red (Molecular Probes) as described previ-
ously (Abu-Issa et al., 2002), with the following modifica-
tions: sterile lactated ringers was substituted for Tyrode’s
buffer; 2–4 AM Lysotrackeri was used for 30 min while
rotating at 37-C under air; embryos were washed 3 times in
lactated ringers and then 4 times in PBS over the course of
30 min at room temperature with gentle inversion. Embryos
were then fixed, dehydrated, and cleared as described
(Zucker et al., 1999).
TUNEL assays were performed to detect apoptotic cells in
paraffin sections. Embryos were fixed in 4% PFA, dehy-
drated, embedded in paraffin, and sectioned at 6 Am. Sections
were deparaffinized, rehydrated, incubated in 2% proteinase
K, permeabilized in 0.1% Triton X-100 in 0.1% sodium
citrate then incubated with TUNEL reaction mixture (1:20
TdT enzyme per TUNEL Label; Roche) for 60 min at 37-C.
Confocal analysis
Embryos with fluorescent secondary antibodies or Lyso-
tracker were analyzed on a Zeiss LSM 410 or LSM 510 meta
Zeiss laser scanning confocal microscope. Z-sectioning series
were obtained from using the same settings for controls and
mutants, which were then stacked and converted to Quick-
time movie images using Zeiss Meta software.Results
Shh/ embryos display conotruncal and pharyngeal arch
artery defects
Late-term Shh/ embryos (e16.5–18.5) had consistent-
ly (100%) abnormal cardiovascular development which
included a single outflow artery arising from the right
ventricle instead of the usual two-vessel configuration
where the pulmonary trunk arises from the right ventricle
and the aorta arises from the left ventricle. The aortic archwas right-sided (normally left-sided) and gave rise to a
single midline carotid artery with abnormal subclavian
arteries (Figs. 1A,B). While the two ventricles were similar
in size, the right was displaced rostrally (pulled up) relative
to the left in Shh/ mutants as previously described (Izraeli
et al., 1999; Tsukui et al., 1999). Overall, the mutant hearts
were smaller (as were the entire embryos) at this stage of
development when compared with controls.
The descending aorta gave rise to abnormal limb arteries;
distal to these were collateral pulmonary arteries directed to
abnormal lung tissue (Figs. 1C,D). There was no ductus
arteriosus. Venous patterning in Shh/ embryos was
notable for abnormal pulmonary vein connections (anoma-
lous pulmonary venous return) as previously reported (data
not shown and Tsukui et al., 1999). These findings are
consistent with developmental abnormalities observed at
earlier stages (see below).
Intracardiac lesions are present in near-term Shh/
embryos
The atrial septum primum and septum secundum were
defective in all mutants examined (n = 5), creating the
appearance of a single, common atrium. The two atrioven-
tricular valves were present in most embryos, but the
distance separating them was abnormally short (Figs. 1E,F),
and in 1 of 5, there appeared to be a single atrioventricular
valve. In general, the myocardium was variably thickened in
near-term Shh/ mutants suggesting hypertrophy. No
pulmonary valve was detected. Finally, the base of the aorta
was shifted rightward with bias to the right ventricle and
over-rode a membranous ventricular septal defect (VSD)
(Figs. 1G,H). The coronary arteries and epicardium were
present and grossly normal.
Aortic arch artery development is abnormal in early Shh/
embryos
In order to understand the pathogenesis of the defects
seen at near term, we next examined the cardiovascular
development of Shh/ embryos between e8.5and e12.5.
Aortic arch artery development in mutants also transgenic
for the endothelial cell marker Tie2-LacZ was compared
with littermate controls. The aortic arch arteries arise as
condensations of endothelial cell precursors and sequential-
ly develop within the mesenchyme of the pharyngeal arches.
In control embryos, progressive development of the first
three aortic arch arteries was evident by e9.5 (Fig. 2A). In
Shh/ embryos, the first three aortic arch arteries were
hypoplastic, with the first aortic arch artery often single and
located at the midline (Fig. 2B). In control embryos, the
third, fourth, and forming sixth aortic arch arteries were
clearly visible by e10.5 (Fig. 2C), while the fourth and sixth
aortic arch arteries in Shh/ embryos did not appear to
develop (Fig. 2D). These data suggest that the right third
arch artery rather than the left fourth persists as the aortic
Fig. 1. Comparison of whole-mount Tie2-LacZ transgenic (A–D) and
histological sections (E–H) of wild type (A,C,E,G) and Shh/ (B,D,F,H)
e16.5 embryos. Ventral view (A,B) demonstrates a single outflow tract (?)
rather than aortic (Ao) and pulmonary artery (Pa) as seen in wild-type
embryos. Dorsal view (C,D) demonstrates a midline descending Ao with
branch pulmonary arteries (BPa) arising from the descending aorta distal to
abnormal limb arteries (Lba) rather than off the main pulmonary artery as in
control (D vs. C arrow). Sectioning of the hearts demonstrates an absent
atrial septum (black arrowhead), abnormal atrioventricular valves (arrows),
and thickened ventricular muscle (F) compared with controls (E). The Ao
outflow was malpositioned (H) between the right and left ventricles (RV
and LV) overriding a ventricular septal defect (VSD). LL—left lung, RL—
right lung, RA—right atrium, LA—left atrium.
Fig. 2. Arch artery development was abnormal in Tie2-LacZ transgenic
Shh/ embryos (B,D) compared to controls (A,C). As early as e9.5, Shh/
embryos have hypoplastic arches (particular 1st arch) and abnormal vascular
endothelial cell pattern (B vs. A). By e10.5, only the right 3rd arch artery is
well formed in Shh/ mutants with no apparent 4th or 6th arch artery
development (D vs. C).
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and the aortic sac in Shh/ embryos was much smaller and
narrower than in controls. This reduction in overall size
appeared to be secondary to the reduced width and size of
the pharyngeal arches and pharyngeal region.
Conotruncal development is abnormal in early Shh/
embryos
We next compared conotruncal development between
Shh/;Tie2-LacZ and control embryos. Surprisingly, OT
lengthening was impaired, and development of the pulmo-
nary portion was deficient prior to the arrival of migratory
NCCs. At e9.0 (23 somites), Shh/ hearts already
demonstrated subtly smaller OT and right ventricle relative
to the inflow and left ventricle (data not shown). At e10.5 (35
somites), when NCCs first enter the OT, there was already a
marked difference in OT and right ventricle length between
mutants and controls (Figs. 3A–D, compare white bars). The
shortening of the OT appears to result in the right ventricle
being ‘‘pulled’’ toward the pharyngeal region relative to the
left ventricle. By e11.5 (43 somites—when NCCs have
populated the OT), the combined length of the OT and right
ventricle were markedly smaller, and the left portion of the
OT lacked an endothelial channel (Figs. 3E–H). In addition,
there appeared to be less rostral/caudal compression of the
endothelial tract (Figs. 3G vs. H, arrowheads). By e12.0–
12.5, the single outflow tract in Shh/ embryos was
continuous with the right third aortic arch artery with a
hypoplastic left 3rd arch artery, while the pulmonary channel
was completely absent (Figs. 3I–L, black arrows). No
consistent defects were noted in the myocardium of e9.5–
12.5 Shh/ embryos, suggesting that any myocardial
abnormalities seen near-term are secondary to pressure/flow
Fig. 3. Outflow tract development was abnormal in Shh/ embryos. Using Tie2-LacZ, outflow tract and ventricular development were visualized after X-Gal
staining in embryos at e10.5 (37 somites: A–D), e11.5 (43 somites: E–H), and e12.5 (I–L). Wt and Shh mutants as marked. White bar is identical in length in
adjacent figures. At 37 somites, both the distal truncus (B vs. A) and conus/right ventricle (D vs. C) of the developing outflow tract were smaller. This
difference persisted and became more apparent particularly in the conus/right ventricular portion of the outflow tract at 43 somites (H vs. G). In addition, the
truncus was thin and the endothelial channel less flattened by presumptive NCCs (G vs. H, white arrowheads). By 43 somites, the pulmonary endothelial
channel was not forming, and a VSD was present between ventricles (I–L), demonstrating development of pulmonary artery atresia.
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pharyngeal arch arteries or a later function of Shh.
Shh/ embryos have hypoplastic pharyngeal arches and
loss of arch derivatives
One of the most striking defects observed by gross
examination of Shh/ embryos at early stages was
abnormal development of the pharyngeal arches. Hypopla-
sia of the first pharyngeal arch could be identified in Shh/
embryos as early as e9.0. The first pharyngeal arches were
abnormally fused in the midline, and the distance between
the remaining left and right pharyngeal arches was
significantly reduced. To evaluate for defects of pharyngeal
arch-derived structures, we examined sections and bone
preparations of Shh/ embryos at e16.5–18.5.
The first through third pharyngeal arches and pouches
contribute to a number of structures such as the face/neck
bones, external/internal ear, as well as several glands in the
neck (thymus, thyroid, and parathyroid glands). Virtually all
of the structures derived from the first through sixth
pharyngeal arches/pouches were abnormal or absent in
Shh/ embryos (data not shown). Craniofacial structures
essentially consisted of only a nasal and otic capsule.Notably, there was a small thymus present in mutants,
consistent with other reports (Fagman et al., 2004; Moore-
Scott and Manley, 2005).
Most or all of the defects described in Shh/ embryos
are consistent with loss of the pharyngeal arch and pouch
derivatives of which NCCs are a major component. In
addition, NCCs are required for arch artery and OT
development. Given previous evidence that Shh signaling
can affect NCC development, we next examined the speci-
fication, migration, and fate of NCCs in Shh/ embryos.
Neural crest cells are specified though migrate abnormally
in Shh/ embryos
NCCs are specified and migrate in Shh/ embryos as
determined by CrabP1 and Ap2a, two markers expressed in
migrating NCCs (Dencker et al., 1990; Mitchell et al.,
1991). We found that, while both CrabP1 and Ap2a were
expressed at grossly normal levels, the pattern of expression
was abnormal in Shh mutants (Figs. 4A–D). CrabP1 was
not expressed in the first arch, and there was fusion of the
post-otic tracts of neural crest (third and fourth arch) into
one broad stream (Fig. 4A vs. B). Similarly, Ap2a, which is
normally expressed in the dorsal neural tube and DRGs and
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misexpressed in tissue including the ventral neural tube of
e10.5 Shh/ embryos (Fig. 4C vs. D). This altered
expression pattern could be the result of abnormal arch
segmentation independent of NCC expression. However,
examination of the endodermally expressed transcription
factor Pax1 demonstrated that the arches were well defined
and separated in Shh/ embryos (Figs. 4E,F). At e11.5, a
general reduction in the number of cells positive for Ap2a
and CrabP1 was seen in Shh/ mutants (data not shown).
The pattern of Ap2a and CrabP1 suggested that NCCs
were migrating along abnormal pathways. To further study
this phenomenon, we examined the expression of the
neurofilament specific antibody, 2H3, which marks the
NCC-derived cranial nerves and DRGs (Figs. 4G–J).
Strikingly, the cranial nerves and DRGs were abnormally
fused and more broadly distributed, respectively, consistent
with the previous Ap2a and CrabP1 mRNA analysis.
Shh/ embryos have a reduced population of NCC
derivatives
To study the fate of NCCs in greater detail, we
generated Shh/ embryos that were also transgenic for
P0-Cre (expressed by migrating NCCs) and the Cre
reporter R26R. This strategy allowed us to effectively
compare lineage marked NCCs in Shh/ embryos and
controls. At e10.5, a marked decrease in h-Gal positive
cells in the pharyngeal arches of Shh/ embryos (data not
shown) suggested that loss of arch tissue in the mutants
resulted from a reduced NCC population. In addition, there
is a general reduction in the expression of LacZ in the
DRGs. By e11.5, this general loss of NCCs is even more
striking (Figs. 4K,L). NCCs did enter the cardiac OT but
appeared to be decreased in number and in an abnormal
pattern in Shh/ embryos. In control hearts, NCCs entered
the outflow tract in two discrete prongs, whereas NCCs
entering the outflow tract in Shh/ embryos were
distributed along the walls and not in distinct prongs of
cells (see Fig. 8). The general reduction in NCC numbersFig. 4. Expression of NCC markers demonstrate induction and migration
but an abnormal pattern in Shh mutants. At e9.5, CrabP1 expression was
absent in the 1st arch, and the distinct streams of NCCs in arches 3–4 were
fused into one (B vs. A and arrow). At e10.5, Ap2a expression was more
widespread than normal with no distinction in the arches (arrowheads), loss
of specific NCC tracts, and diffuse signal in areas of the trunk (arrow) in
Shh mutants (D vs. C). Expression of the endodermal specific marker Pax1
demonstrated that the arches were well segmented in Shh mutants like
controls, although expression was missing from the developing somites (E–
F). Examination of cranial nerves (CN) and DRGs utilizing the neurofila-
ment antibody 2H3 (see Materials and methods) demonstrated fusion of CN
7, 9, and 10 in Shh mutants (G vs. H) as well as abnormal DRGs and
sympathetic chain ganglia with indistinct borders (I vs. J). Lineage trace of
NCCs (K–L) utilizing P0-Cre and the Cre reporter R26R (see Materials and
methods) demonstrated a reduced number of NCC derivatives with marked
reduced population within the craniofacial region and arches as well as
abnormal or absent DRGs by e11.5 (arrows). O—otocyst.
Fig. 5. Confocal laser optical sections of whole-mount Lysotracker-treated
embryos demonstrated excessive cell death in Shh mutants (E–G, K–M, P)
when compared with controls (A–C, K–M, O). At e9.0 (A–G), lateral to
medial sagittal sections revealed increased cell death in the neural tube and
cells adjacent to the neural tube of a Shh mutant (arrows in panels E–G vs.
A–C). At e10.0–10.5 (H–P), there was increased cell death in cells of the
pharyngeal arches as well as around the cyclopic eye and forebrain (arrows)
and pharyngeal endoderm (arrowheads) of Shh mutants (K–M v. H–J).
Higher magnification demonstrated the marked death of cells approaching
the outflow tract (OT) contiguous with cushions and endothelial channel, as
well as throughout the endoderm (arrows in panel P vs. O). A—atrium, V—
Ventricle.
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survive in Shh/ embryos. Together, these results indicate
that NCCs are specified but localize abnormally and are
markedly reduced in number as early as e10.5.
NCCs proliferate normally in Shh/ embryos
Given the reduced number, we next examined cell
proliferation of NCCs using an anti-phospho-histone H3
antibody that labels cells in metaphase. Confocal laser
microscopy optical sections of e9.5 and e10.5 embryos
demonstrated no significant difference in proliferation
within the arches of Shh/ embryos (n = 3) compared to
control littermates (data not shown). However, we cannot
rule out that subtle differences in proliferation, or changes in
proliferation occurring at earlier stages, contribute to the
decreased NCCs seen in these mutants.
Shh/ embryos exhibit increased cell death within the
arches and pharyngeal endoderm
We examined cell death in whole mount Shh/ embryos
by using both TUNEL (data not shown) and the fluorophore
Lysotracker Red which indicates necrotic or dying cells
(Zucker et al., 1999). Strikingly, there were marked areas of
increased cell death in the arches of Shh/ embryos.
Confocal laser optical sections demonstrated that at e9.0
there were small amounts of cell death in the forebrain and
at the mid-hindbrain boundary of control embryos (Figs.
5A–C). In contrast, Shh/ mutants had a marked increase
in cell death in forebrain, midbrain, around the developing
eye, and cells adjacent to the neural tube (suggestive of
migratory NCCs) (Figs. 5E–G). These zones of cell death
are consistent with the defects previously described in these
mutants, including forebrain and mid-hindbrain defects
(Chiang et al., 1996; Moore-Scott and Manley, 2005). At
e10.0, there were several small areas of cell death in wild
type embryos, including a moderate population migrating
from the mid-hindbrain region into the first pharyngeal arch
(data not shown), a smaller population immediately around
the developing otocyst, and a population at the proximal
junction of the first and second pharyngeal arches (Figs.
5H–J). In Shh/ embryos, there was a dramatic increase in
cell death in cells of the developing arches, as well as cell
death present in the developing pharyngeal endoderm.
Optical sections revealed that virtually all of the first and
second arch mesenchymal cells were dying, particularly
distal arch cells (Figs. 5K–M). At e10.5, the endoderm and
presumptive NCCs entering the outflow tract were also
dying, unlike controls (Figs. 5O,P).
Ptch1 expression suggests a role for Shh in NCC
localization
In order to understand how loss of Shh affects
pharyngeal arch, NCCs, and cardiovascular development,we next examined the expression of Shh and its receptor
Ptch1, which reflects the extent of SHH signaling (and
other Hedgehog family members) from the source of
expression (Goodrich et al., 1997; Zhang et al., 2001). As
previously reported, Shh mRNA is extensively expressed
within the pharyngeal arch endoderm (Jeong et al., 2004).
However, no expression in mesenchyme of the arches,
around the developing arch arteries or within the OT, was
detected (Figs. 6A,B and data not shown). Ptch1 mRNA
and Ptch1LacZ expression were both examined and were
similar. The expression of both Ptch1 mRNA and
Ptch1LacZ is much more extensive than Shh expression
itself. Within the developing pharyngeal arches, expression
Fig. 6. Comparison of Shh mRNA expression to ß-Gal activity from Ptch1LacZ demonstrated broader expression of Ptch1LacZ reflecting diffusion of Hedgehog
pathway signals (A vs. C). Within the ventral pharyngeal region, Shh (B) was present and restricted to the endoderm, while Ptch1LacZ (D) was in both
endoderm and adjacent mesenchyme with high expression in the developing thyroid. The Ptch1LacZ (E) and Gli1 mRNA (F) domains in Shh/ embryos were
restricted to the developing gut at e10.5 when compared to controls (C and G), indicating that no other family member was actively signaling in the pharyngeal
region or neural tube at these stages. Ptch1 mRNA (H) and to a greater extent Ptch1LacZ (I) were expressed into the OT at e10.5 of wild-type embryos
(arrowheads). Ptch1LacZ was expressed in two prongs that spiral into the OT (J) and continued to be expressed in the septating OT (K).
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into the mesenchyme of the arches (Figs. 6C,D and Jeong
et al., 2004). To determine to what extent Ptch1LacZ
pharyngeal expression reflects SHH signaling and not that
of other Hedgehog family members, we examined the
expression of Ptch1LacZ in Shh/ embryos. Between
e9.5–11.5, significant h-Gal activity was detected only in
the developing gut and not within the arches or the OT
(Fig. 6E vs. C). To confirm that signaling through other
members, perhaps through Ptch2 receptor, was not
occurring within the pharyngeal endoderm, we also
examined expression of Gli1, another direct downstream
target of Hedgehog signaling. Similar to Ptch1LacZ,
expression of Gli1 was seen only in the developing gut
of Shh/ embryos at this stage (Fig. 6F vs. G), indicating
that pharyngeal arch expression of Ptch1 is mediated by
SHH at these stages.
One surprising area of Ptch1 expression was within the
developing OT itself (Fig. 6H), which was more apparent
with the LacZ allele than mRNA (Fig. 6I). This expression
started as early as e9.5 and persisted through septation of the
OT (e12.5). Initially, two lines of expression extended into
the distal OT (Fig. 6J) and later surrounded the developing
distal aorta and pulmonary trunk (Fig. 6K). Ptch1LacZ
expression was noted in the outflow of Shh/ embryos
after e11.5, suggesting that other Hedgehog signaling family
members may be active in heart development at later stages
(data not shown).
Given the observed NCC deficits and the pattern of
Ptch1LacZ expression, we next asked whether SHH acts
directly on NCCs by determining if NCCs express the
Ptch1 receptor. To address this issue, we compared somite
stage-matched Ptch1LacZ and P0-Cre;R26R embryos stained
for ß-Gal activity. We found that, between e9.5–11.5,
Ptch1LacZ expression was essentially absent from NCCs andinstead complimentary to lineage traced NCCs with little
apparent overlap.
At e10.5, Ptch1 expression was seen in mesenchyme
medially, whereas NCCs migrating into the pharyngeal
arches populate more lateral regions (Figs. 7A–D vs. E–H).
As cells enter the OT, Ptch1 expression encompasses the
ventral pharynx, including the septum forming from the
dorsal aortic sac, while NCCs are adjacent (Figs. 7A,B vs.
E,F). Around the arch arteries, Ptch1 expression is restricted
to the medial region, while P0-Cre-marked NCCs are
localized laterally (Fig. 7C vs. G). Through e11.5, this
complimentary pattern of Ptch1 expression relative to NCCs
remained consistent. Whereas pharyngeal tissue more
dorsal–medial remains Ptch1 positive, NCCs remain more
lateral in discrete domains (Figs. 7I–L vs. M–P). These
relatively mutually exclusive domains persist into the OT as
well (Fig. 7K vs. O). Sectioning of e10.5 outflow tracts
revealed that Ptch1 expression was present in the myocar-
dial wall of the OT adjacent to areas where endothelial cells
abut the myocardial wall to the exclusion of NCCs (Figs.
7Q–S vs. T–V). This pattern suggests that one possible role
for Shh signaling at this stage may be to restrict the domains
that NCCs populate. This pattern was also present in other
areas of NCC development such as the developing stomach,
where NCC-derived enteric neurons form (Figs. 7W,X). To
confirm that our P0-Cre transgene was faithfully marking
NCC, we also examined Wnt1-Cre lineage traced NCC at
e11.5. While there are differences in the pattern generated
by P0-Cre versus Wnt1-Cre, a similar complimentary
pattern to Ptch1LacZ was obtained (Fig. 7M vs. MV). These
data indicate that Ptch1 is not expressed by the majority of
NCCs, and, therefore, SHH does not signal directly to a
significant number of NCCs at these stages.
Our examination of OT development suggested that the
defects in pulmonary artery development primarily occurred
Fig. 7. Ptch1LacZ expression was complementary to NCC derivatives between e10.5 and e11.5. Somite-matched Ptch1LacZ (A–D, I–L, Q–S) were compared
with P0-Cre:R26R (E–H, M–P, T–V) embryos. Approximate pharyngeal frontal sections (white bars D) showed NCC to be excluded from Ptch1LacZ
domains at both e10.5 (A–D vs. E–H) and e11.5 (I–L vs. M–P). Arrows in complementary sections (i.e., A vs. E) demonstrate where Ptch1 expression was
present and NCCs were not. Sections through e10.5 OT localized Ptch1LacZ to the areas where the endothelial channel abuts the myocardium to the exclusion
of NCCs (arrows Q–S vs. T–V). The relationship of NCCs to Ptch1LacZ persisted in other areas of NCC migration such as the gut where NCC-derived enteric
neurons populate (W vs. X). P0-Cre:R26R (M) results were comparable to Wnt1-Cre:R26R (M V).
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that perhaps the pulmonary artery was absent because the
pulmonary endothelial channel was being obstructed by
abnormal NCC localization in Shh/ mutants. We therefore
examined stage-matched e10.5 hearts from Shh/ and
control embryos to compare NCC, Ptch1LacZ, and Tie-LacZ
expression patterns (Fig. 8).
As previously demonstrated in section, the expression of
Ptch1LacZ is complimentary to NCC localization and
apparently adjacent to where endothelial cells are closest
to the myocardial wall (Figs. 8A–F). Comparison of the
NCC to the endothelial patterning again demonstrates thatthere is a significant reduction in the NCCs entering as the
OT of Shh/ embryos. The OT is narrower, and there is no
cranial–caudal compression of the endothelial channel by
NCCs as seen in controls (Fig. 8I vs. J). However, some
NCCs do enter the outflow tract but appear as a bolus of
cells in the area of the forming pulmonary artery (Figs.
8G,K vs. H,L, and Figs. 3J,N). Interestingly, this area
appears to correspond to where Ptch1LacZ is expressed and
where the pulmonary artery connects to the forming sixth
arch arteries (Figs. 8F,K,L). We confirmed this finding by
lineage tracing NCCs in Shh/ embryos. Examination of
the outflow tract reveals a diffuse pattern of reduced NCC
Fig. 8. Analysis of NCC, Ptch1LacZ, and endothelial cell markers during OT septation in removed hearts at e11.5. Hearts are viewed as marked. Whole-mount
wild-type NCC pattern compared to Ptch1LacZ confirmed the complementary pattern (A,C,E vs. B,D,F). At the same stage, Tie2-LacZ staining demonstrated
abnormal endothelial compression by NCCs in Shh mutants (G,I,K vs. H,J,L). A bolus of cells was present in the OT of mutants (arrow H,L) that corresponded
with the location of the developing pulmonary artery (Pa in K) as well as the location of Ptch1LacZ expression (arrows in D,F) and absent NCCs (arrows C, E).
NCC tracing in Shh/ embryos confirmed decreased and abnormal distribution of cells in whole-mount e12.5 OT (M vs. N) and sectioned e11.5 embryos (O
vs. P arrow).
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revealed a more diffuse representation of NCCs during
septation when compared to controls (Fig. 8O vs. P). These
data indicate that less NCCs populate the OT and that they
are mislocalized in Shh/ embryos.
NCC derivatives are mislocalized in Shh/ embryos
To further pursue our observation that NCCs are
mislocalized, we examined other non-cardiovascular struc-
tures in Shh/ embryos. Ap2a mRNA expression in the
developing neural tube of Shh mutants was localized
throughout the neural tube but appeared absent laterally in
whole mount at e11.5. However, upon closer examination,
expression was seen ventral to the neural tube (Figs. 9A–
C). In addition, Shh/;P0-Cre;R26R embryos clearly
demonstrated that DRGs are fused at the ventral midline,
with neuronal tracts abnormally crossing the midline (Figs.
9E,F) where Ptch1LacZ is normally expressed (Fig. 9D). In
addition to crossing the midline, DRGs were also fused in
the rostral–caudal axis (Figs. 9H,I). Examination ofPtch1LacZ showed lateral segmented expression domains
(Fig. 9G), suggesting that Shh signaling is critical for
separating the NCC-derived DRGs in this axis, as well as
left and right sides. Examination of the pharyngeal arches
also demonstrated ectopic localization of NCCs to the dorsal
pharyngeal region and other areas (Figs. 9J–L, 8O).
Interestingly, examination of the stomach and gut demon-
strated relatively normal localization of neural crest derived
enteric neurons consistent with the continued expression of
Ptch1LacZ (reflecting Hedgehog signaling other than SHH
within the gut). Furthermore, in the area of the developing
abdomen, the DRG development was more segmental,
suggesting perhaps some rescue from other Hedgehog
signals localized within the gut (Fig. 4L and data not
shown).
How are NCCs indirectly affected by SHH signaling?
We detected loss of NCCs both at the time of dela-
mination as well as during migration. This loss must be
primarily indirect as Ptch1 does not appear to be expressed
Fig. 9. NCC derivatives were mislocalized in Shh mutant embryos in areas
where Ptch1LacZ was normally expressed. The NCC marker Ap2a expressed
in the dorsal neural tube and DRGs (A) was expanded into the ventral neural
tube as well as across the midline below the neural tube (C vs. B). e11.5
sections of NCC trace compared to Ptch1LacZ showed the DRG axons
abnormally crossing the midline in Shh mutants (F vs. E) where Ptch1LacZ is
normally expressed (D). In addition, the DRGs were fused in the midline as
predicted by Ap2a expression (arrows I vs. H). However, these defects are
not restricted to the ventral neural tube area as the DRGs were also fused in
the A–P axis (I vs. H arrowheads) where Ptch1LacZ also had a segmental
pattern (G). This fusion was consistent with the neuronal staining of cranial
nerves and DRGs (Figs. 4J–M). Lineage traced NCCs were also abnormally
seen in the dorsal pharyngeal region and midline of Shh/ embryos (arrows
L vs. K) as well as the OT of the heart (Fig. 7), all corresponding with areas
of normal Ptch1LacZ expression. These data strongly suggest that NCC
derivatives are mislocalized in Shh/ embryos. O—otocyst, P—pharynx,
AS—aortic sac.
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has been implicated in the early development of NCCs
(Aybar et al., 2002; Baker and Bronner-Fraser, 1997).
We therefore examined for changes in Bmp expression in
Shh/ embryos. Significantly, we noted a marked reduc-
tion in Bmp4 expression in the dorsal ectoderm of Shh
mutant embryos. This change in Bmp expression might
explain early loss of NCCs. However, lineage tracing of
NCCs revealed significant loss within the arches also,
consistent with later morphological defects seen in Shh/
embryos. Analysis of cell death revealed a striking patternof apoptosis of NCCs and pharyngeal endoderm within the
arches. Examination of four NCC markers, Crabp1, Ap2a,
Twist, and Sox9, revealed significant differences in patterns
of expression. While Crabp1, Twist, and Sox9 were absent
from the first arch, Ap2a continued to be expressed within
the arch ectoderm (Fig. 10 and data not shown). In
addition, Sox9 expression was absent or reduced in several
significant places including the distal pharyngeal arches
and the developing DRGs and/or somites (Figs. 10C,D).
Strikingly, the loss of Sox9 at e9.5 and 10.5 matched the
pattern of apoptosis seen in three-dimensional reconstruc-
tions of cell death in Shh/ embryos (Fig. 10I). This also
correlated with the areas where NCCs were missing in the
arches and the DRGs as determined by NCC lineage
tracing (Figs. 10G,H and data not shown). While this loss
of expression may represent dead cells, the continued
expression of Ap2a in the same cells, both mRNA and
protein (data not shown), suggests that maintenance of
Sox9 expression in NCCs is lost in Shh/ embryos,
possibly resulting in their death.Discussion
Shh/ embryos demonstrate a developmental mechanism
for pulmonary artery atresia
Evaluation of Shh/ embryos near term revealed a
single OT arising from both ventricles. This conformation is
suggestive of conotruncal septation failure. However, OT
development in Shh/ embryos is abnormal prior to the
onset of septation with clear absence of the forming
pulmonary artery (Figs. 3A–H). Our results suggest that
the pulmonary artery fails to form in Shh/ embryos, not
because of a failure of conotruncal septation, but rather due
to hypoplasia of the caudal ventral pharynx and failure to
form the fourth and sixth aortic arch arteries. In addition,
shortening of the OT may contribute to the abnormal
pulmonary artery development. Loss of these structures
appears to result in a failure to maintain the endothelial
channel that normally forms the pulmonary artery. The third
arch artery then presumably compensates for the loss of the
fourth arch artery to become the aortic arch and maintain the
cardiac circulation. Our data also suggest that mislocaliza-
tion of NCCs within the OT channel may partially obstruct
the pulmonary channel, possibly contributing to the
observed phenotype. While the etiology of the agenesis of
the fourth and sixth arches (and arteries) remains unclear,
extensive cell death in the pharyngeal endoderm and NCCs
of the arches seems the most likely cause.
Shh, Ihh, and the anterior heart field
As early as e8.75, shortening of the OT can be seen in
Shh/ embryos. At this stage, Shh/ embryos are difficult
to distinguish in size and morphology from wild type
Fig. 10. Whole-mount mRNA in situ demonstrated loss of dorsal surface ectoderm expression of Bmp4 in e10.5 Shh mutants (A vs. B). Sox9 expression was
abnormal as early as e9.5 in Shh mutants (C vs. D) and the domains of lost expression match those where NCCs are absent (G,H). There was increased cell
death (I) where Sox9 was missing in the 1st arch (arrow) and trunk (arrowheads) of similar-staged Shh mutant embryos (C,D,I). In addition, general somite
segmentation was present as late as e10.5 in Shh mutants, indicating that the A–P fusion of the DRGs was not a general phenomenon (E,F arrowhead) but
more specific to NCC derivatives.
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simply due to growth retardation. The smaller OT appears to
be the source of the ‘‘pulling up’’ of the right ventricle
observed in Shh/ embryos (Izraeli et al., 1999; Tsukui et
al., 1999), a process described in manipulated chick
embryos with a shortened outflow tract (Yelbuz et al.,
2002, 2003). Why are the outflow tracts and right ventricle
of Shh/ embryos reduced? Recent data have demonstrat-
ed that the normal growth of the OT and right ventricle are
dependent on the newly described anterior heart field (Abu-
Issa et al., 2004; Cai et al., 2003; Kelly and Buckingham,
2002; Mjaatvedt et al., 2001). Interestingly, Ihh;Shh double
null mutants or Smo mutants have more severe heart defects
than Shh/ embryos (Zhang et al., 2001). These defects
imply that Ihh in combination with Shh are critical for early
development of myocardial precursors, possibly the anterior
heart field. Whether Ihh and/or Shh play some combinato-
rial role in the development of the anterior heart field
remains to be determined.
Shh/ cardiovascular defects resemble tetralogy of Fallot
In addition to pulmonary artery atresia, Shh/ embryos
have VSDs as well as an overriding aorta and variable
ventricular hypertrophy. This constellation of cardiac
phenotypes resembles a defined syndrome, tetralogy of
Fallot (TOF). Complete pulmonary artery atresia with VSD
is considered to be the most severe form of this syndrome(Adams et al., 1983). Interestingly, other defects in Shh/
embryos such as atrial septal defects, right aortic arch,
atrioventricular canal, and anomalous pulmonary venous
return have all been associated with pulmonary artery atresia
with VSD (Bharati et al., 1975). Intriguingly, loss of the
SHH receptor SMO results in loss of Nkx2.5 expression in
the mouse. In humans, the Nkx2.5 gene has also been
implicated in TOF, particularly TOF with pulmonary atresia
(Goldmuntz et al., 2001; Zhang et al., 2001). This suggests
that a conserved signaling pathway involving SHH induc-
tion of Nkx2.5 may be defective in some humans with TOF
like lesions.
Previously, Shh/ mutants have been suggested to be
a model for human Vacterl (Vater) association as mutants
also have renal, vertebral, and anal defects (Kim et al.,
2001). Indeed, TOF is a reported cardiac defect seen in
Vacterl association (Garne et al., 1999). In addition, TOF,
particularly with pulmonary atresia, is also highly
associated with the 22q11deletion syndrome (Chessa et
al., 1998; Maeda et al., 2000) In looking for human SHH
mutations, Nanni and colleagues examined patients with a
single midline incisor, a mild form of holoprosencephaly.
In the 12 patients examined, two had Vacterl syndrome,
and two had 22q11deletion syndrome. Strikingly, 3 of 12
were also diagnosed with TOF. While mutations in the
coding region of SHH were not identified in these three
particular patients, regulatory regions of the Shh gene
were not examined (Nanni et al., 2001).
I. Washington Smoak et al. / Developmental Biology 283 (2005) 357–372 369Recent studies examining candidate genes contained
within the 22q11deletion region have implicated loss of
the transcription factor Tbx1 as causative for some of the
observed phenotypes (Jerome and Papaioannou, 2001;
Lindsay et al., 2001; Merscher et al., 2001; Yagi et al.,
2003). We and others have shown that Shh/ embryos
have arch artery defects similar to those seen in Tbx1
mutants and that ectopic expression of Shh can result in
upregulation of Tbx1. In addition, Tbx1 has been implicated
in anterior heart field development (Hu et al., 2004; Xu et
al., 2004), consistent with our data for Shh mutants
presented here. Furthermore, Shh can regulate Tbx1
expression through Fox family transcription factors
(Foxc2), indicating a regulatory relationship between Shh
and Tbx1 (Garg et al., 2001; Yamagishi et al., 2003).
Supporting this finding, Jeong et al. (2004) provide strong
evidence that Hedgehog signaling in craniofacial mesen-
chyme also acts through multiple Fox gene members
including Foxc2. Finally, Foxc1;Foxc2 double mutants are
reported to also have anterior heart field defects (T. Kume,
pers. comm.).
Our data coupled with these studies suggest that defects
in the Shh signaling pathway may account for some patients
with pulmonary atresia. Patients who also have the 22q11
deletion, Vacterl syndrome, and/or mild midline forebrain/
craniofacial defects would be of particular interest to study
for defects in the Shh signaling pathway.
Shh effect on NCC appears indirect between e9.5 and 11.5
The majority of pharyngeal arch tissue is derived from
migratory NCCs with contributions from endoderm,
ectoderm, and paraxial/lateral plate mesoderm. NCCs are
required for development of not only the aortic arch
arteries and OT septation, but also for craniofacial bones,
endocrine organs of the neck, auditory ossicles, sympa-
thetic ganglia, and dorsal root ganglia. Virtually all of
these structures are missing or defective in Shh/
embryos. Within the arches, NCCs in Shh mutants
undergo extensive aberrant cell death, primarily in the
distal first and second arches. Ptch1LacZ expression
suggests SHH diffuses and signals to adjacent mesen-
chyme within the arches, but not directly to NCCs
between e9.5 and 10.5 as Ptch1LacZ is not coexpressed
to any significant degree in lineage traced NCCs.
Supporting this observation is the finding that tissue-
specific deletion of Smo from migratory NCCs has no
visible early (e8.5–10.5) phenotype on NCC derivatives
(Jeong et al., 2004), while Shh/ embryos have visible
pharyngeal defects as early as e9.0. Furthermore, work
with neural tube explants supports an indirect role for
SHH. NCCs do not egress from the neural tube when
exposed to SHH protein from all sides, an effect that is
PTCH-receptor-independent (Testaz et al., 2001). This
indicates that SHH signaling to NCCs during these stages
is primarily indirect or occurs without induction of Ptch1.Ptch1 expression suggests that Shh may function in a
pathway of NCC exclusion/repulsion
One of the surprising findings in this study is the
complementary expression of Ptch1LacZ relative to NCCs
between e9.5–11.5. This suggests that the Hedgehog
signaling pathway may restrict the domains that NCCs can
populate. Signals emanating from the ventral neural tube act
to repulse and prevent DRG axons from crossing the
midline (Masuda et al., 2004). In Shh/ embryos, we see
evidence of mislocalization of NCC derivatives such as the
trigeminal ganglion and the DRGs, which are fused across
the midline. These findings cannot simply be due to loss of
midline structures as the DRGs are also fused in the rostral–
caudal axis as well. The fusion of DRGs in this axis could
be accounted for by the loss of somite segmentation as a
physical barrier due to cell death of the developing somites.
While some somite markers at these stages are absent (Pax1
in Figs. 4E,F), Twist continues to be expressed in a
segmental pattern, suggesting that physical segmentation
remains intact at these stages (Figs. 10E,F).
Recent evidence that SHH can act as an axonal migration
chemo-attractant in the floor plate adds further support for
Shh gene signaling acting as a guidance factor (direct or
indirect) of NCCs (Charron et al., 2003). Roles in both
repulsion and attraction depending on target tissue have
been shown for other guidance factors. Importantly, a role
for Shh in dorsal commissural neuron repulsion has also
been reported (Bourikas et al., 2005). Interestingly, this
repulsion also appeared to be independent of Ptch1
expression and was HIP (hedgehog interacting protein)-
dependent. Three other studies support this model: (1)
NCCs have altered cell adhesion properties and fail to
migrate from neural tube explants exposed to exogenous
SHH (Testaz et al., 2001). (2) SHH can also suppress retinal
ganglion axon outgrowth in vitro (Trousse et al., 2001). (3)
GDNF-induced migration of enteric NCCs can be inhibited
by SHH protein (Fu et al., 2004). Our data in combination
with these studies suggest that Shh gene signaling can act
either directly or indirectly as a chemo-attractant or a
repulsive factor depending on the developmental context.
Therefore, these data suggest that Shh is necessary for
some secondary mediator produced from the non-NCC
mesenchyme and/or endoderm which guides NCCs. Loss of
this guidance information appears to result in significant
loss of NCCs through cell death. This factor(s) appears to be
important at both the time of delamination and during NCC
migration as Shh/ embryos have defective NCC devel-
opment at both stages.
Although dorsal patterning (where NCCs are generated)
is thought to essentially remain intact, we have detected
abnormal dorsal specification in Shh/ embryos. Specifi-
cally, we have found that surface ectodermal expression of
Bmp4 is absent around the dorsal neural tube (Figs. 10A,B).
Tissue-specific deletion of the Bmp receptor 1a gene from
migratory NCCs results in their loss and OT septation
I. Washington Smoak et al. / Developmental Biology 283 (2005) 357–372370defects (Stottmann et al., 2004). Interestingly, loss of the
Bmp4 inhibitor gene Chordin can result in a 22q11deletion
syndrome-like phenotype through alterations in NCC
development, suggesting that both gain and loss of Bmp
signaling can negatively affect NCCs (Bachiller et al.,
2003). In addition, loss of function of Bmp4 can result in
OT defects, although these appear to be direct effects on the
developing heart (and possibly the anterior heart field), not
related to NCCs (Liu et al., 2004).
As Bmp signaling is thought to be critical for the
development of NCCs, we cannot rule out misspecification
at the time of delamination. Indeed, we noted significant
increased cell death in the area of delaminating NCCs in
Shh/ embryos (Figs. 5E–G). However, other data
presented here suggest that specification and delamination
are grossly normal. Marker analysis (Ap2a and Crabp1) and
P0-Cre;R26R lineage tracing suggest that NCCs are
specified and migrate into the pharyngeal arches, but either
take abnormal routes or pass through tissue from which they
are normally restricted and subsequently undergo apoptosis.
In addition, studies in chick have demonstrated that
blocking SHH function with antibody can result in NCC
death after migrating from a presumably normally patterned
neural tube, suggesting that Shh is required after specifica-
tion and migration (Ahlgren and Bronner-Fraser, 1999).
Analysis of cell death revealed a striking pattern of
apoptosis within the NCCs and pharyngeal endoderm. In
addition, lineage tracing of NCCs revealed significant loss
of NCC derivatives within the arches consistent with later
morphological defects seen in Shh/ embryos. Strikingly,
the pattern of cell death matched the loss of Sox9 expression
in Shh/ embryos and correlated with the areas where
NCCs were missing (Figs. 10G,H,I, and data not shown).
Sox9 has been implicated in the differentiation but not
the induction of NCCs (Cheung and Briscoe, 2003), and
SHH can induce Sox9 (Zeng et al., 2002). Heterozygous
loss of Sox9 results in bone differentiation defects including
inner ear, jaw, and palate defects (Bi et al., 2001). Sox9+/
mouse embryos die shortly after birth from undefined
causes. Tissue-specific deletion of Sox9 in NCCs using
Wnt1-Cre results in bone and OT cushion defects, similar to
Shh-/- embryos but milder (Mori-Akiyama et al., 2003;
Akiyama et al., 2004). Therefore, it seems likely that loss of
Shh results in failure to maintain Sox9 expression and other
factors resulting in the NCC-associated loss of arch-derived
bone structures and possible OT defects.
In summary, loss of Shh affects several cell populations
important in pharyngeal and cardiovascular development.
NCCs are specified and migrate (including into the OT) but
are mislocalized and undergo apoptosis, possibly through a
combination of altered Bmp signaling and loss of Sox9
expression. SHH does not appear to signal directly to NCCs
between e9.5 and e11.5 but rather appears to induce/
suppress a secondary survival/apoptotic factor. Mislocaliza-
tion of NCCs may also contribute to the loss of NCCs
observed. The OT septation defects are not due solely to lossof NCCs but rather to a general failure of caudal pharyngeal
development. This failure results in no formation of the
fourth and sixth arch arteries and results in pulmonary artery
atresia. In addition, mislocalized NCCs may act to obstruct
the developing pulmonary artery. Finally, effects on OT and
right ventricular development may also be in part caused by
a requirement for Shh on anterior heart field development.
The summation of these defects results in a phenotype that
resembles the most severe form of TOF. Hedgehog
signaling coordinates multiple aspects of cardiovascular
growth and development. Determining how the NCCs,
anterior heart field, and endoderm are linked in coordinating
the growth and development of the cardiovascular system
will be an active area of future investigation.Acknowledgments
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